Process Development

Bern, Switzerland

Process Development

Bern, Switzerland

Time filter

Source Type

News Article | May 9, 2017
Site: www.prweb.com

Bio-gen Extracts Pvt. Ltd, a privately held specialty ingredient development and cGMP manufacturing company of food and dietary ingredients, custom botanical extracts, food additives and novel oleoresins, has selected Ingredient Identity a preeminent regulatory management consulting firm specializing in the Food, Dietary Supplement and Cosmetic industries, to support their growth and ingredient distribution initiatives throughout North and South America. “Founded in 2000, Bio-gen Extracts set out to develop superior ingredients with proven practices of sustainability, exceptional quality based in good science, and most importantly to be a company that leads by example in all we do,” said Saif Mehkri, Managing Director of Bio-gen Extracts. “Today we have an amazing ingredient portfolio created by a robust clinical-driven approach that leads our ingredient development in Europe, the Americas, South East Asia, Australia and South Africa. Key to our future planning and growth initiatives, is conducting the proper regulatory due diligence of a target market. This is followed by developing clear goals that shape our business and regulatory strategies to entering those markets or introducing new ingredients into existing markets. Moreover, differentiating our ingredients with sound scientific and clinical data is essential to ensuring the success of our customers’ products. The know-how of driving such growth by striking the right balance of achieving key business objectives while meeting the compliance requirements optimally, is why we chose Ingredient Identity.” “We’re extremely pleased to have been selected by Bio-gen Extracts to support their new growth initiatives here in the US, Canada and throughout several key Latin American countries,” said Brandon Griffin, CEO of Ingredient Identity. “When it comes to bringing new ingredients to a given market, there are a number of approaches companies can take, but each carry significant costs, risks and timing considerations. More specifically, there are critical business and regulatory factors to be aware of, and value-chain’s that need to be well-defined, so conducting the right level of due diligence is essential to one’s long term success. Bio-gen Extracts is a company that truly embodies this management mindset and is committed to ingredient development best practices that drive the overall success of their customers.” Bio-gen Extracts flagship 40,000 sqft Manufacturing & Research facility in Dobaspet, Bangalore is the headquarters of all operations, and maintains certifications in ISO, GMP, HACCP, OHSAS, FSSAI, HALAL and KOSHER. The state-of-the-art production and laboratory equipment allows the company to compete globally in increasingly competitive markets, while maintaining strict safety, quality and labor standards across all products and ingredients. The company currently lists over 30 SKU’s and on average develops over seven new or novel ingredients each year. About Bio-gen Extracts Bio-gen Extract’s is an ingredient development and cGMP manufacturing company based in Bangalore, India, offering support for R&D, Pilot-scale Production, Process Development Consulting Services and Large-scale Custom Ingredient Manufacturing. The company has a rigorous and systematic approach to project management, which is complemented by an experienced staff with excellent technical and practical problem-solving skills. For more information on Bio-gen Extracts products and services, visit the company's website at: http://bio-gen.in About Ingredient Identity Ingredient Identity is a preeminent regulatory management consultancy supporting companies through-out the supply chains of the Food & Beverage, Dietary Supplement, Animal Feed and Cosmetic industries worldwide. The company specializes in Quality and Regulatory guidance, cGMP Facility Auditing, FDA compliance, Litigation Consulting, Quality Program Optimization as well as New Dietary Ingredient and GRAS Notifications. For more information, please visit: http://www.ingredientidentity.com


CAMBRIDGE, Mass.--(BUSINESS WIRE)--Unum Therapeutics, a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat multiple cancers, today announced that the Company has been selected to deliver two presentations on its Antibody-Coupled T cell Receptor (ACTR) platform at the 2017 ASGCT Annual Meeting, which is being held in Washington DC, May 10-13, 2017. The oral presentation will describe a systematic Design of Experiments approach to identify manufacturing processes for T cell products exhibiting persistent activity and reduced propensity for exhaustion. The poster presentation will provide data exploring the activity landscape of ACTR, identifying variants with optimized function for use in challenging therapeutic environments. Building A Better T-Cell: T Cell Process Development by Multifactorial Design of Experiments Approach and High Throughput Automated Functional Assays Date & Time: Wednesday, May 10, 2017 – 4:00PM Eastern Time Session: Oral Abstract Session II - Engineering and Manufacturing Vectors and Cells I Abstract Number: 85 Location: Room Virginia ABC Presenter: Geoff Hodge, Chief Technical Officer Unum Therapeutics Inc. Date & Time: Friday, May 12, 2017 - 5:45-7:45PM Eastern Time Session: Cancer-Targeted Gene and Cell Therapy II Abstract Number: 603 Location: Exhibit Hall A & B South Presenter: Kathleen McGinness, PhD, Director, Platform Technologies, Unum Therapeutics Inc. The poster will be posted on Unum’s website following the presentations. About Antibody-Coupled T cell Receptor (ACTR) Technology Unum’s proprietary ACTR is a chimeric protein that combines components from receptors normally found on two different human immune cell types – natural killer (NK) cells and T cells – to create a novel approach to cancer cell killing. T cells bearing the ACTR receptor protein can be directed to attack a tumor by combining with a monoclonal antibody that binds antigens on the cancer cell surface. In contrast to other T cell therapy approaches for cancer that are limited to a single cancer cell surface target and, therefore, treat a narrow set of tumors, Unum’s approach is not restricted by a specific tumor cell antigen and, thus, may have applications for treating many different types of cancers when combined with the right antibody. Unum is developing ACTR in combination with a range of tumor-targeting antibodies for use in both hematologic and solid tumor indications. ACTR087, Unum’s most advanced product candidate, combines Unum’s proprietary ACTR with rituximab, an anti-CD20 antibody. The ACTR087 study is the first clinical trial using a viral vector to permanently insert the ACTR gene into the genome of patients’ T cells. About Unum Therapeutics Unum Therapeutics uses its proprietary Antibody-Coupled T cell Receptor (ACTR) technology in combination with tumor-targeting antibodies, which is designed to activate the body’s own immune system to fight cancer. Unum is actively building a pipeline of ACTR programs in which proprietary, tumor-targeting antibodies are armed to improve their therapeutic potential. The Company is headquartered in Cambridge, MA. For more information, visit www.unumrx.com/.


News Article | May 23, 2017
Site: phys.org

Recycling plastic has an important role in sustainable manufacturing. However, there are still barriers to using recycled plastic not only because of its material and processing properties but also because of its smell. A young researcher at Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) has now studied what causes recycled plastic to smell. Each year several tons of plastic waste are produced in Germany, for example from packaging. Around 50 percent of this waste is burnt. Recycling and reusing this waste could protect the environment in the long term and conserve fossil resources. However, recycled plastic is still not used enough in manufacturing due to undesirable contaminants. The Fraunhofer Institute for Process Engineering and Packaging (IVV) is developing and enhancing recycling processes for mixed post-consumer plastic waste. FAU doctoral candidate Miriam Strangl is studying the scents of plastic waste and recycled products to find the cause of unpleasant odours in a collaborative project with the departments of Sensory Analytics and Process Development for Polymer Recycling at the Fraunhofer Institute. Strangl characterises samples through an olfactometric and analytical approach by evaluating the quality and intensity of their scent. After this, she deciphers the odorous substances and identifies them. Strangl's highly-trained nose is key to deciphering these odourous substances in her doctoral research which is supervised by Prof. Dr. Andrea Büttner (Professor for Aroma Research at FAU). She can identify the molecules of a range of compounds by their smell alone and confirms these findings through chemical analysis. 'The different substances found in plastic packaging waste have a number of different smells. These include mouldy, cheesy or acidic smelling molecules,' explains Strangl. 'We were able to identify some of these strong-smelling contaminants in plastics for the first time ever. In addition, the results showed that, apart from odorous substances from previous contents such as food or cleaning agents, other processes might also lead to the unpleasant odours' says Strangl. In addition to microbiological decay, this also includes aging plastics or the decomposition of residues from manufacturing such as solvents. The findings of the study will help scientists to develop strategies for reducing odours in recycled plastics. The results of the study were published in the Journal of Separation Science under the title: 'Characterisation of odorous contaminants in post-consumer plastic packaging waste using multidimensional gas chromatographic separation coupled with olfactometric resolution'. More information: Miriam Strangl et al, Characterization of odorous contaminants in post-consumer plastic packaging waste using multidimensional gas chromatographic separation coupled with olfactometric resolution, Journal of Separation Science (2017). DOI: 10.1002/jssc.201601077


News Article | May 25, 2017
Site: www.sciencedaily.com

Recycling plastic has an important role in sustainable manufacturing. However, there are still barriers to using recycled plastic not only because of its material and processing properties but also because of its smell. A young researcher at Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) has now studied what causes recycled plastic to smell. Each year several tons of plastic waste are produced in Germany, for example from packaging. Around 50 percent of this waste is burnt. Recycling and reusing this waste could protect the environment in the long term and conserve fossil resources. However, recycled plastic is still not used enough in manufacturing due to undesirable contaminants. The Fraunhofer Institute for Process Engineering and Packaging (IVV) is developing and enhancing recycling processes for mixed post-consumer plastic waste. FAU doctoral candidate Miriam Strangl is studying the scents of plastic waste and recycled products to find the cause of unpleasant odours in a collaborative project with the departments of Sensory Analytics and Process Development for Polymer Recycling at the Fraunhofer Institute. Strangl characterises samples through an olfactometric and analytical approach by evaluating the quality and intensity of their scent. After this, she deciphers the odorous substances and identifies them. Strangl's highly-trained nose is key to deciphering these odourous substances in her doctoral research which is supervised by Prof. Dr. Andrea Büttner (Professor for Aroma Research at FAU). She can identify the molecules of a range of compounds by their smell alone and confirms these findings through chemical analysis. 'The different substances found in plastic packaging waste have a number of different smells. These include mouldy, cheesy or acidic smelling molecules,' explains Strangl. 'We were able to identify some of these strong-smelling contaminants in plastics for the first time ever. In addition, the results showed that, apart from odorous substances from previous contents such as food or cleaning agents, other processes might also lead to the unpleasant odours' says Strangl. In addition to microbiological decay, this also includes aging plastics or the decomposition of residues from manufacturing such as solvents. The findings of the study will help scientists to develop strategies for reducing odours in recycled plastics.


News Article | May 1, 2017
Site: www.businesswire.com

DANBURY, Conn.--(BUSINESS WIRE)--In support of its continued drive to be the leading innovator in the global polymer additive market, Addivant™ announced today the promotion of Dr. Hayder Zahalka as Addivant’s first Research Fellow. This designation is recognized globally as an expert in a technology platform area as evidenced by peer-reviewed publications, patents and major contributions to an industry. In his announcement to the company, John Steitz, CEO stated, “Hayder is recognized globally and is our foremost technical expert on polyethylene and elastomer technologies. He is our primary technical contact with PE and elastomer customers demonstrating the value of WESTON® 705. We are very fortunate to have such a leading global expert on our team and continue to expect great innovations from Hayder and our entire R&D organization.” Dr. Zahalka holds a Bachelor of Science in Chemistry-Biochemistry, a Master of Science in Applied Chemistry, and a PhD in Catalysis and Process Development from the Hebrew University of Jerusalem. Additionally, he completed a Post-Doctoral Fellowship in Organometallic Chemistry at the University of Ottawa. Dr. Zahalka is Addivant’s leading presenter at national and international conferences, with 39 papers delivered globally since 2008. He is an inventor or co-inventor on 6 granted patents and 2 pending applications. Addivant™ is an innovator in the field of polymer additives, developing customized solutions that provide customers enhanced application performance, safe handling, and reduction in cost of use. The company is recognized industry-wide for its extensive portfolio of specialty additives including antioxidants, light stabilizers, rubber additives, polymer modifiers, metal deactivators, polymerization inhibitors, and intermediates. Addivant is an international company with 11 plants on five continents, as well as research, manufacturing, and sales facilities around the globe. The company maintains its global headquarters in Connecticut, USA, with regional headquarters in Al Jubail, Saudi Arabia, Basel, Switzerland, and Shanghai, China. Addivant is an independent portfolio company of SK Capital. Visit www.addivant.com for more information. ADDIVANT™, WESTON®, ANOX®, POLYBOND®, LOWINOX®, ULTRANOX®, GENOX®, NAUGARD® and FLEXAMINE® are trademarks of Addivant.


News Article | April 25, 2017
Site: marketersmedia.com

Latest Niche Market Research Study on “Global Network Cache and Accelerator Market Research Report and Forecast to 2016-2020” Published At Orbisresearch.ComDallas, United States - April 25, 2017 /MarketersMedia/ — This market analysis includes a detailed segmentation of the Global Network Cache and Accelerator Market by development trend and by application. The report covers the present year 2017 scenario and the growth prospects of the Global Network Cache and Accelerator Market for 2016-2020. The report Global Network Cache and Accelerator Market 2016-2020 has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market. The report also covers the market landscape and its growth prospects over the coming years. The Network Cache and Accelerator Market By Geography • North America • Asia-Pacific • Europe Request a sample of Global Network Cache and Accelerator Market Research Report @ http://www.orbisresearch.com/contacts/request-sample/181503 . The Global Network Cache and Accelerator Market research report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Global Network Cache and Accelerator Market key players are: • Company A • Company B • Company C • Company D Browse the full Global Network Cache and Accelerator Market Research Report @ http://www.orbisresearch.com/reports/index/global-network-cache-and-accelerator-market-research-report-and-forecast-to-2016-2020 . The report provides an extensive analysis of current and future market status of the world Network Cache and Accelerator market. Some of the points from table of content: Industry Overview • Definition • Classification Share Analysis • Application Analysis Market Analysis • Product Development History • Process Development History • Competitive Landscape Analysis Industry Development Trend • Capacity Production Overview • Production Market Share Analysis • Demand Overview Market Status and Forecast • Supply Demand and Shortage • Import Export Consumption • Cost Price Production Value Gross Margin Reasons for Buying this Global Network Cache and Accelerator Market Research Report • This report helps to analyzed the world's main region market conditions • It provides product manufacturing processes • It provides industry policies and plans • It provides overview of product specification • It provides cost structures & so on. The Report Contains: 157 Pages. Price of the report: 2850$ (single user license) Check discount @ http://www.orbisresearch.com/contacts/discount/181503 . Contact Info:Name: Hector CostelloEmail: sales@orbisresearch.comOrganization: Orbis ResearchAddress: 4144N Central Expressway, Suite 600,Phone: 2148846817Source URL: http://marketersmedia.com/global-network-cache-and-accelerator-market-growth-analysis-and-2020-forecast/189951For more information, please visit http://www.orbisresearch.com/reports/index/global-network-cache-and-accelerator-market-research-report-and-forecast-to-2016-2020Source: MarketersMediaRelease ID: 189951


Latest Niche Market Research Study on “Global Mobile Pocket Cloud Network Accelerator Market Research Report and Forecast to 2017-2021” Published At Orbisresearch.ComDallas, United States - April 25, 2017 /MarketersMedia/ — This market analysis includes a detailed segmentation of the Global Mobile Pocket Cloud Network Accelerator Market by development trend and by application. The report covers the present year 2017 scenario and the growth prospects of the Global Mobile Pocket Cloud Network Accelerator Market for 2016-2020. The report Global Mobile Pocket Cloud Network Accelerator Market 2016-2020 has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market. The report also covers the market landscape and its growth prospects over the coming years. The Mobile Pocket Cloud Network Accelerator Market By Geography • North America • Asia-Pacific • Europe Request a sample of Global Mobile Pocket Cloud Network Accelerator Market Research Report @ http://www.orbisresearch.com/contacts/request-sample/181498 . The Global Mobile Pocket Cloud Network Accelerator Market research report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Global Mobile Pocket Cloud Network Accelerator Market key players are: • Company A • Company B • Company C • Company D Browse the full Global Mobile Pocket Cloud Network Accelerator Market Research Report @ http://www.orbisresearch.com/reports/index/global-mobile-pocket-cloud-network-accelerator-market-research-report-and-forecast-to-2016-2020 . The report provides an extensive analysis of current and future market status of the world Mobile Pocket Cloud Network Accelerator market. Some of the points from table of content: Industry Overview • Definition • Classification Share Analysis • Application Analysis Market Analysis • Product Development History • Process Development History • Competitive Landscape Analysis Industry Development Trend • Capacity Production Overview • Production Market Share Analysis • Demand Overview Market Status and Forecast • Supply Demand and Shortage • Import Export Consumption • Cost Price Production Value Gross Margin Reasons for Buying this Global Mobile Pocket Cloud Network Accelerator Market Research Report • This report helps to analyzed the world's main region market conditions • It provides product manufacturing processes • It provides industry policies and plans • It provides overview of product specification • It provides cost structures & so on. The Report Contains: 157 Pages. Price of the report: 2850$ (single user license) Check discount @ http://www.orbisresearch.com/contacts/discount/181498 . Contact Info:Name: Hector CostelloEmail: sales@orbisresearch.comOrganization: Orbis ResearchAddress: 4144N Central Expressway, Suite 600,Phone: 2148846817Source URL: http://marketersmedia.com/mobile-pocket-cloud-network-accelerator-market-global-analysis-2017-2021-forecast-report/189918For more information, please visit http://www.orbisresearch.com/reports/index/global-mobile-pocket-cloud-network-accelerator-market-research-report-and-forecast-to-2016-2020Source: MarketersMediaRelease ID: 189918


This report studies the global High Throughput Process Development market, analyzes and researches the High Throughput Process Development development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Market segment by Type, High Throughput Process Development can be split into Instrument Software and Service Market segment by Application, High Throughput Process Development can be split into Monoclonal Antibodies Recombinant Insulin Global High Throughput Process Development Market Size, Status and Forecast 2022 1 Industry Overview of High Throughput Process Development 1.1 High Throughput Process Development Market Overview 1.1.1 High Throughput Process Development Product Scope 1.1.2 Market Status and Outlook 1.2 Global High Throughput Process Development Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 High Throughput Process Development Market by Type 1.3.1 Instrument 1.3.2 Software and Service 1.4 High Throughput Process Development Market by End Users/Application 1.4.1 Monoclonal Antibodies 1.4.2 Recombinant Insulin 2 Global High Throughput Process Development Competition Analysis by Players 2.1 High Throughput Process Development Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Danaher Corporation 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 GE Healthcare 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Agilent Technologies 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 Merck Millipore 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 Thermo Fisher Scientific 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Bio-Rad Laboratories 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 Eppendorf AG 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 Perkinelmer, Inc 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 Sartorius Stedim Biotech 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Tecan Group Ltd. 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 High Throughput Process Development Revenue (Value) (2012-2017) 3.10.5 Recent Developments 4 Global High Throughput Process Development Market Size by Type and Application (2012-2017) 4.1 Global High Throughput Process Development Market Size by Type (2012-2017) 4.2 Global High Throughput Process Development Market Size by Application (2012-2017) 4.3 Potential Application of High Throughput Process Development in Future 4.4 Top Consumer/End Users of High Throughput Process Development For more information, please visit https://www.wiseguyreports.com/sample-request/1206536-global-high-throughput-process-development-market-size-status-and-forecast-2022


News Article | May 8, 2017
Site: www.prnewswire.com

West Palm Beach, FL - HappyOrNotⓇ, the global leader in instant customer and employee satisfaction reporting, is in high demand with local governments as they search for tools to measure and improve their government services. "Local and municipal governments across the U.S. face an increasingly informed and vocal electorate. Many government officials are using the power of sentiment to improve their customer experience, accountability and transparency," said Heikki Väänänen, CEO and Founder of HappyOrNot. "This is all in an effort to raise the quality of life of their citizens, enhance public perception, and address the financial impact of poor customer satisfaction." According to a recent column1 published by Governing, "Poor government services have real consequences that are particularly acute for businesspeople. Licensing delays can derail financing for a start-up. Misunderstanding a regulation can lead to a restaurant owner closing down and laying off staff. Permitting problems can cost a contractor his customers and investors." It is no surprise that the priority for many local governments is to implement strategic plans to enhance customer service. One such example is Adams County which is using the HappyOrNot customer feedback service to do just that. The county has placed a feedback kiosk, known as a Smiley Terminal™, in their Community & Economic Development department to design the department's service strategies around input from customers. Adams County completed a reorganization back in July 2015, and, by mid-September, the feedback terminal was deployed. According to Andrea Berg, Customer and Process Development Manager, it didn't take long for the department to quickly take ownership of the results gathered by the device. "My team routinely encourages customers to use the terminal after they have helped them. They really take pride in the service they provide. If a customer leaves gives negative feedback by pressing a red face smiley button, the team member will immediately inform me and let me know what happened. This provides a great opportunity for training by helping the team think of better options to handle a difficult situation." Adams County is currently working on implementing HappyOrNot's virtual feedback service, Web Smileys™, to know how their newly introduced online system is being received by web visitors. "We recently launched a new online permitting system for building permits and initial reviews for land use cases. We want to be able to capture how well this is working or what is not working by using the Web Smileys," she added. At King County, government officials are giving their residents and business owners a chance to get involved so that they are able to serve them better. In their Treasurer's office, they have put extra emphasis on customer service. "Sometimes we have a message that isn't easy to deliver and can be hard for customers to take, but we can deliver it courteously and respectfully," says Property Tax Supervisor Mark Thompson. The team at King County uses the HappyOrNot service to get immediate feedback to help recognize exceptional staff, learn from them, and improve the process where needed. In 2015, the Riverside City Council endorsed seven strategic priorities, listing Enhanced Customer Service as the top priority. According to Lea Deesing, the Riverside's Chief Innovation Officer, the ultimate goal of employing the feedback service is to improve services, engage citizens and supplement the citywide performance measurement program. Subsequently, Riverside's individual departments implemented HappyOrNot's customer satisfaction polling service to serve as its baseline satisfaction measurement tool. In February 2017, eleven Smiley Terminals were deployed around city hall and other locations. The city also implemented Web Smileys for its websites to help capture the online sentiment. In addition to monitoring their external service quality, Riverside, in an effort to remain competitive with the other IT markets, has installed a Smiley Terminal in its Innovation and Technology Department to monitor internal morale. After each workday employees are able to answer anonymously, "How was your day?" The overall objective is to stay on the pulse of the department's daily work atmosphere. City of Riverside joins a growing number of private sector organizations like Microsoft, Nike, Domino's and many others in deploying HappyOrNot terminals to engage their employees and measure workplace satisfaction. In a Government Technology article2, Phil Pitchford, the city's communications officer stated, "The idea is that if you've gotten a permit and want to get on with the rest of your day, you probably don't want to take a 15-minute survey and we most likely won't get a response." He continued, "It's something, you can do your business at city hall, push a button and leave." Some examples of what the city wants to know from its constituents, both in-person and online, include: Residents and business owners answer these questions by simply pressing a button ranging from very happy (dark green smiley face) to very unhappy (dark red smiley face). Every time someone presses one of the buttons, the data is fed wirelessly to a web-based collection and reporting system to chart how well city employees are serving the public. Performance results are emailed at the end of every day and are available 24/7 via the HappyOrNot reporting portal. The cloud-based reporting service includes "tampering filters" that are designed to "filter out" children playing with the buttons or employees attempting to game the system. The HappyOrNot service is proving to be a good fit for many other cities like Atlanta, Miami, Redding, Las Cruces, and Kettering, and counties like Washoe and Clackamas - to name a few. Municipal and county governments can quickly monitor customer satisfaction levels, create reports for improving government processes, monitor and improve employee engagement and, ultimately, improve the quality of life of their citizens. "Riverside takes customer service very seriously, and HappyOrNot is a great tool to document the satisfaction level of the public," Mayor Rusty Bailey said. "I look forward to seeing the data in terms of how well we are doing and where we can improve." 1William Eggers and Greg Pellegrino, "The Customer-Experience Prescription for Government," Governing, October 18, 2016 2Theo Douglas, "Through Data, Customers Tell Riverside If They're 'Happy Or Not', Government Technology, March 17, 2017 This information was brought to you by Cision http://news.cision.com http://news.cision.com/happyornot/r/us-cities-and-counties-are-asking-their-citizens-are-they--happy-or-not-,c2257129 The following files are available for download: To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/happyornot---us-cities-and-counties-are-asking-their-citizens-are-they-happy-or-not-300453023.html


ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Co-Chief Executive Officer Michael D. West, Ph.D. will present at Terrapinn’s World Advanced Therapies & Regenerative Medicine Congress, May 17-19 at Business Design Centre in London. Titled “Applying Artificial Intelligence to Stem Cell Biology,” Dr. West’s presentation is scheduled for Friday, May 19 at 11:40 a.m. BST. Expanding on a presentation Dr. West gave last year, it will provide an update on deep learning algorithms and their potential to unlock mechanisms of tissue regeneration for applications in age-related disease, and how these insights will dovetail with BioTime’s recently-announced subsidiary, AgeX Therapeutics. Additionally, on the first day of the conference, Wednesday, May 17, Dr. West will present at a plenary roundtable discussion with seven other senior-level executives, including Jane Lebkowski, Ph.D., Chief Scientific Officer and President of Research & Development at BioTime affiliate company Asterias Biotherapeutics. Titled “Process Development & Manufacturing Focus,” the session will begin at 11:40 a.m. BST. More information about the World Advanced Therapies & Regenerative Medicine Congress is available here. BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies developed from what the company believes to be the world’s premier collection of pluripotent cell assets. The foundation of BioTime’s core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. Pluripotent cells have potential application in many areas of medicine with large unmet patient needs, including various age-related degenerative diseases and degenerative conditions for which there presently are no cures. Unlike pharmaceuticals that require a molecular target, therapeutic strategies based on the use of pluripotent cells are generally aimed at regenerating or replacing affected cells and tissues, and therefore may have broader applicability than pharmaceutical products. BioTime also has significant equity holdings in two publicly traded companies, Asterias Biotherapeutics, Inc. and OncoCyte Corporation, which BioTime founded and which, until recently, were majority-owned consolidated subsidiaries of BioTime. BioTime common stock is traded on the NYSE MKT and TASE under the symbol BTX. For more information, please visit www.biotimeinc.com or connect with the company on Twitter, LinkedIn, Facebook, YouTube, and Google+.

Loading Process Development collaborators
Loading Process Development collaborators